These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 701794)

  • 1. Enhancement of human eosinophil complement receptors by pharmacologic mediators.
    Anwar AR; Kay B
    J Immunol; 1978 Oct; 121(4):1245-50. PubMed ID: 701794
    [No Abstract]   [Full Text] [Related]  

  • 2. Human eosinophil- and neutrophil-mediated killing of schistosomula of Schistosoma mansoni in vitro. I. Enhancement of complement-dependent damage by mast cell-derived mediators and formyl methionyl peptides.
    Anwar AR; McKean JR; Smithers SR; Kay AB
    J Immunol; 1980 Mar; 124(3):1122-9. PubMed ID: 7358978
    [No Abstract]   [Full Text] [Related]  

  • 3. The ECF-A tetrapeptides and histamine selectively enhance human eosinophil complement receptors.
    Anwar AR; Kay AB
    Nature; 1977 Oct; 269(5628):522-4. PubMed ID: 909604
    [No Abstract]   [Full Text] [Related]  

  • 4. H1-receptor dependence of histamine-induced enhancement of human eosinophil C3b rosettes.
    Anwar AR; Kay AB
    Clin Exp Immunol; 1980 Oct; 42(1):196-9. PubMed ID: 6109584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophils and mediators of anaphylaxis. Histamine and imidazole acetic acid as chemotactic agents for human eosinophil leucocytes.
    Immunology; 1976 Nov; 31(5):797-802. PubMed ID: 992712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression by prostaglandin E1 of vascular permeability induced by vasoactive inflammatory mediators.
    Fantone JC; Kunkel SL; Ward PA; Zurier RB
    J Immunol; 1980 Dec; 125(6):2591-6. PubMed ID: 7430639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the eosinophil.
    Kay AB
    J Allergy Clin Immunol; 1979 Aug; 64(2):90-104. PubMed ID: 458057
    [No Abstract]   [Full Text] [Related]  

  • 8. IgG and complement receptors on purified mouse eosinophils and neutrophils.
    López AF; Strath M; Sanderson CJ
    Immunology; 1981 Aug; 43(4):779-86. PubMed ID: 6456221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the complement system in antigen-induced bronchoconstriction and changes in blood pressure in the guinea pig.
    Regal JF; Fraser DG; Toth CA
    J Pharmacol Exp Ther; 1993 Nov; 267(2):979-88. PubMed ID: 8246173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of neutrophil- and eosinophil-mediated complement-dependent killing of schistosomula of Schistosoma mansoni in vitro by leukotriene B4.
    Moqbel R; Sass-Kuhn SP; Goetzl EJ; Kay AB
    Clin Exp Immunol; 1983 Jun; 52(3):519-27. PubMed ID: 6307558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptors for C3 and IgG on macrophage, neutrophil and eosinophil colony cells grown in vitro.
    Rabellino EM; Metcalf D
    J Immunol; 1975 Sep; 115(3):688-92. PubMed ID: 1167213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The regulation of human eosinophil function by endogenous mono-hydroxy-eicosatetraenoic acids (HETEs).
    Goetzl EJ; Weller PF; Sun FF
    J Immunol; 1980 Feb; 124(2):926-33. PubMed ID: 7356719
    [No Abstract]   [Full Text] [Related]  

  • 13. Modulation of human eosinophil polymorphonuclear leukocyte migration and function.
    Goetzl EJ
    Am J Pathol; 1976 Nov; 85(2):419-36. PubMed ID: 793410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of complement in innate, adaptive and eosinophil-dependent immunity to the nematode Nippostrongylus brasiliensis.
    Giacomin PR; Gordon DL; Botto M; Daha MR; Sanderson SD; Taylor SM; Dent LA
    Mol Immunol; 2008 Jan; 45(2):446-55. PubMed ID: 17675237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotactic factor-induced enhancement of the binding of human immunoglobulin classes and subclasses to neutrophils and eosinophils.
    Kay AB; Walsh GM
    Clin Exp Immunol; 1984 Sep; 57(3):729-34. PubMed ID: 6088141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further studies on the chemotactic factor of complement and its formation in vivo.
    Ward PA; Cochrane CG; Muller-Eberhard HJ
    Immunology; 1966 Aug; 11(2):141-53. PubMed ID: 4162237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The IgE-mediated release of an eosinophil leukocyte chemotactic factor from human lung.
    Kay AB; Austen KF
    J Immunol; 1971 Sep; 107(3):899-902. PubMed ID: 4105937
    [No Abstract]   [Full Text] [Related]  

  • 18. Binding of immunoglobulin classes and subclasses to human neutrophils and eosinophils.
    Walsh GM; Kay AB
    Clin Exp Immunol; 1986 Feb; 63(2):466-72. PubMed ID: 3698341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human eosinophil adherence to serum-treated sepharose: granule-associated enzyme release and requirement for activation of the alternative complement pathway.
    Metcalfe DD; Gadek JE; Raphael GD; Frank MM; Kaplan AP; Kaliner M
    J Immunol; 1977 Nov; 119(5):1744-50. PubMed ID: 915279
    [No Abstract]   [Full Text] [Related]  

  • 20. Activation of antibody-dependent cell-mediated cytotoxicity of human neutrophils and eosinophils by separate colony-stimulating factors.
    Vadas MA; Nicola NA; Metcalf D
    J Immunol; 1983 Feb; 130(2):795-9. PubMed ID: 6600255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.